Why is Zenith Drugs falling/rising?

As of 18-Aug, Zenith Drugs Ltd is experiencing a decline in its stock price, currently at 62.95, which represents a decrease of 1.35 or 2.1%. The stock has underperformed its sector by 2.41% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has fallen by 3.15%, and it has seen a significant drop of 14.35% over the past month. Year-to-date, the stock is down 22.09%, and over the past year, it has decreased by 24.93%. While there has been a rise in investor participation, with a 55.17% increase in delivery volume on August 14, the overall negative returns and underperformance against benchmarks suggest a challenging environment for the stock.
In the broader market context, the Sensex has shown a positive return of 1.19% over the past week and a 5.21% increase year-to-date, indicating that the overall market is performing well compared to Zenith Drugs. The stock's significant underperformance against the benchmark highlights a lack of investor confidence and potential issues specific to the company. Despite the increase in trading volume, which could suggest some interest, the prevailing downward trend in the stock price indicates that broader market conditions and company-specific challenges are outweighing any positive signals.